MAP2 and isolated focal cortical dysplasia type II: To analyze GFAP and MAP2 immunoexpression, we randomly sampled ten fields per section in the neocortical region where the neuropathological findings characteristic of FCD type II, such as loss of cortical lamination and dysmorphic neurons—along with balloon cells in type IIb—were observed.